Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Quarterly Results    (ALKE)

Here are the latest quarterly results of . For more details, see the financial fact sheet and share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-16
*
3
Jun-16
*
3
Dec-16
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m11,42614,57912,747 
Other income Rs m426281330 
Turnover Rs m11,85214,85913,078 
Expenses Rs m9,84511,86810,394 
Gross profit Rs m1,5742,6662,319 
Depreciation Rs m260230244 
Interest Rs m107100170 
Profit before tax Rs m1,6332,6182,235 
Tax Rs m1,066230345 
Profit after tax Rs m5672,3881,889 
Gross profit margin %13.818.318.2 
Effective tax rate %65.38.815.5 
Net profit margin %5.016.414.8 
Diluted EPS Rs 4.7 20.0 15.8  
Diluted EPS (TTM) Rs NA NA NA  
 Subscriber Feature        
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   WYETH LTD  TTK HEALTHCARE  PANACEA BIOTECH  AMAR REMEDIES  TORRENT PHARMA  

Compare ALKEM LABORATORIES With:   WYETH LTD  TTK HEALTHCARE  PANACEA BIOTECH  AMAR REMEDIES  TORRENT PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Volatile Day for Indian Indices: Sensex Ends 131 Points Lower Post Rebound; Telecom and Auto Stocks Bleed(Closing)

It was a volatile day for India share markets today. The benchmark indices opened higher but turned volatile.

Views on news

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus (Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 27, 2020 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - ASTRAZENECA PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS